forazapadin
AssetAlso SAT-3247
Inhibits AAK1 to restore muscle stem cell asymmetric division and promote muscle regeneration.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Stem cell maintenance
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Duchenne muscular dystrophy
Phase 2, satellos.com, 10 Oct 2026
Facioscapulohumeral muscular dystrophy
Phase 2, Not yet recruiting, NCT07872306, clinicaltrials.gov, 16 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors1
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.